These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28408242)

  • 21. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
    Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ
    Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab')2 against highly pathogenic avian influenza H5N1 in mice.
    Zhao Z; Yan F; Chen Z; Luo D; Duan Y; Yang P; Li Z; Peng D; Liu X; Wang X
    Int Immunopharmacol; 2011 Dec; 11(12):2000-6. PubMed ID: 21906698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG antibodies mediate protective immunity of inactivated vaccine for highly pathogenic H5N1 influenza viruses in ferrets.
    Shin JS; Kim HS; Cho SH; Seo SH
    Viral Immunol; 2010 Jun; 23(3):321-7. PubMed ID: 20565295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of ferrets from infection by swine-origin 2009 A (H1N1) influenza virus by the inactivated vaccine.
    Shin JS; Do Hwang S; Kim HS; Cho SW; Seo SH
    Viral Immunol; 2010 Aug; 23(4):395-402. PubMed ID: 20712484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
    Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
    Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
    J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.
    Hung IFN; To KKW; Lee CK; Lee KL; Yan WW; Chan K; Chan WM; Ngai CW; Law KI; Chow FL; Liu R; Lai KY; Lau CCY; Liu SH; Chan KH; Lin CK; Yuen KY
    Chest; 2013 Aug; 144(2):464-473. PubMed ID: 23450336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H7N9 Influenza Virus Is More Virulent in Ferrets than 2009 Pandemic H1N1 Influenza Virus.
    Yum J; Ku KB; Kim HS; Seo SH
    Viral Immunol; 2015 Dec; 28(10):590-9. PubMed ID: 26421365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.
    Govorkova EA; Webby RJ; Humberd J; Seiler JP; Webster RG
    J Infect Dis; 2006 Jul; 194(2):159-67. PubMed ID: 16779721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
    Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
    Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza.
    Kreil TR; Mc Vey JK; Lei LS; Camacho L; Wodal W; Kerschbaum A; Segura E; Vandamme E; Gavit P; Ehrlich HJ; Barrett PN; Baker DA
    Transfusion; 2012 Apr; 52(4):803-9. PubMed ID: 21981280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of hyperimmune serum for severe influenza infections*.
    Rockman S; Maher D; Middleton D
    Crit Care Med; 2012 Mar; 40(3):973-5. PubMed ID: 22001587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets.
    Nachbagauer R; Miller MS; Hai R; Ryder AB; Rose JK; Palese P; García-Sastre A; Krammer F; Albrecht RA
    J Virol; 2015 Dec; 90(6):3268-73. PubMed ID: 26719251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
    Haasbach E; Droebner K; Vogel AB; Planz O
    J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.
    Lalor PA; Webby RJ; Morrow J; Rusalov D; Kaslow DC; Rolland A; Smith LR
    J Infect Dis; 2008 Jun; 197(12):1643-52. PubMed ID: 18513153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung.
    Vidaña B; Martínez J; Martínez-Orellana P; García Migura L; Montoya M; Martorell J; Majó N
    Vet Res; 2014; 45(1):85. PubMed ID: 25163545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.